Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rhys Williams

Showing results (151-160 of 195) with videos related to

Pageof 20
Sort By:
Diabetes Care|December 18, 2007
Time to insulin initiation cannot be used in defining latent autoimmune diabetes in adultsSinead Brophy, Knud Yderstraede, Didac Mauricio, et al.
Scientific Reports|February 14, 2023
Revealing Corynebacterium glutamicum proteoforms through top-down proteomicsReynaldo Magalhães Melo, Jaques Miranda Ferreira de Souza, Thomas Christopher Rhys Williams, et al.
Annals of the New York Academy of Sciences|December 7, 2007
Cyclin D1 overexpression permits the reproducible detection of senescent human vascular smooth muscle cellsDominick G A Burton, Angela N Sheerin, Elizabeth L Ostler, et al.
Medical Teacher|December 10, 2009
What influences student experience of Graduate Entry Medicine? Qualitative findings from Swansea School of MedicineFrances Rapport, Gwen F Jones, Shaun Favell, et al.
Perioperative Medicine (London, England)|March 16, 2021
Can wearable technology be used to approximate cardiopulmonary exercise testing metrics?Laura Jones, Laura Tan, Suzanne Carey-Jones, et al.
BMC Endocrine Disorders|July 26, 2008
Randomized, controlled, parallel-group prospective study to investigate the clinical effectiveness of early insulin treatment in patients with latent autoimmune diabetes in adultsSinead Brophy, Helen Davies, Stephen Bain, et al.
Oncology and Therapy|September 13, 2025
Indirect Comparisons of the Efficacy and Safety of Zanubrutinib versus Venetoclax plus Obinutuzumab in Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaTalha Munir, Nicolás Martinez-Calle, Sheng Xu, et al.
Blood Cancer Journal|May 2, 2024
Similar efficacy of ibrutinib arms across ALPINE and ELEVATE-RR trials in relapsed/refractory chronic lymphocytic leukemia: a matching-adjusted indirect comparisonMazyar Shadman, Alessandra Tedeschi, Leyla Mohseninejad, et al.
Diabetes Research and Clinical Practice|September 14, 2019
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9<sup>th</sup> editionPouya Saeedi, Inga Petersohn, Paraskevi Salpea, et al.
Therapeutic Advances in Medical Oncology|July 14, 2025
Efficacy of zanubrutinib versus acalabrutinib for relapsed or refractory chronic lymphocytic leukemia (R/R CLL): a matching-adjusted indirect comparison (MAIC)Mazyar Shadman, Jennifer R Brown, Rhys Williams, et al.
Pageof 20

Showing results (151-160 of 195) with videos related to

Sort By:
Pageof 20
Diabetes Care|December 18, 2007
Time to insulin initiation cannot be used in defining latent autoimmune diabetes in adultsSinead Brophy, Knud Yderstraede, Didac Mauricio, et al.
Scientific Reports|February 14, 2023
Revealing Corynebacterium glutamicum proteoforms through top-down proteomicsReynaldo Magalhães Melo, Jaques Miranda Ferreira de Souza, Thomas Christopher Rhys Williams, et al.
Annals of the New York Academy of Sciences|December 7, 2007
Cyclin D1 overexpression permits the reproducible detection of senescent human vascular smooth muscle cellsDominick G A Burton, Angela N Sheerin, Elizabeth L Ostler, et al.
Medical Teacher|December 10, 2009
What influences student experience of Graduate Entry Medicine? Qualitative findings from Swansea School of MedicineFrances Rapport, Gwen F Jones, Shaun Favell, et al.
Perioperative Medicine (London, England)|March 16, 2021
Can wearable technology be used to approximate cardiopulmonary exercise testing metrics?Laura Jones, Laura Tan, Suzanne Carey-Jones, et al.
BMC Endocrine Disorders|July 26, 2008
Randomized, controlled, parallel-group prospective study to investigate the clinical effectiveness of early insulin treatment in patients with latent autoimmune diabetes in adultsSinead Brophy, Helen Davies, Stephen Bain, et al.
Oncology and Therapy|September 13, 2025
Indirect Comparisons of the Efficacy and Safety of Zanubrutinib versus Venetoclax plus Obinutuzumab in Treatment-Naïve Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaTalha Munir, Nicolás Martinez-Calle, Sheng Xu, et al.
Blood Cancer Journal|May 2, 2024
Similar efficacy of ibrutinib arms across ALPINE and ELEVATE-RR trials in relapsed/refractory chronic lymphocytic leukemia: a matching-adjusted indirect comparisonMazyar Shadman, Alessandra Tedeschi, Leyla Mohseninejad, et al.
Diabetes Research and Clinical Practice|September 14, 2019
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9<sup>th</sup> editionPouya Saeedi, Inga Petersohn, Paraskevi Salpea, et al.
Therapeutic Advances in Medical Oncology|July 14, 2025
Efficacy of zanubrutinib versus acalabrutinib for relapsed or refractory chronic lymphocytic leukemia (R/R CLL): a matching-adjusted indirect comparison (MAIC)Mazyar Shadman, Jennifer R Brown, Rhys Williams, et al.
Pageof 20